Anastomosis, Roux-en-Y: Clinical Trials

14 trials of Anastomosis, Roux-en-Y, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 unknown, 2 recruiting, 1 active not recruiting. 7 Not applicable, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 4, Recruiting 1, Terminated 1, Unknown 1
Phase 34Unknown 3, Recruiting 1
Phase 11Completed 1

Follow Anastomosis, Roux-en-Y: new trials by email Literature Review of Anastomosis, Roux-en-Y trials Research Report on Anastomosis, Roux-en-Y

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer
Billroth 2 (B2), Roux-En-Y (REY) - Gastric (Cardia, Body) Cancer
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris2502026-03-202026-05-20
Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers
Bariatric Surgery - MASLD, T2DM (Type 2 Diabetes Mellitus)
Active not recruitingRoyal College of Surgeons in Ireland - Medical University of Bahrain1632025-01-012025-09-15
Roux-en-Y Gastric Bypass Versus Loop Gastrojejunostomy for Malignant Gastric Outlet Obstruction
Roux-en-Y Bypass, gastrojejunostomy - Malignant Gastric Outlet Obstruction
Not applicableTerminatedCorewell Health West52023-08-172026-07-16
Role of the Microbiota in Obesity: Effect After Bariatric Surgery
Bariatric surgery - Obese Patients With Bariatric Surgery
Not applicableCompletedCelia Bañuls602021-03-032025-12-18
Roux-en-Y Gastric Bypass: Clinical Trial
GASTRIC BYPASS MODIFIED IN ROUX-EN-Y AS A THERAPEUTIC OPTION IN PATIENTS WITH INDICATION OF BARIATRIC AND / OR METABOLIC SURGERY - Obesity
Not applicableUnknownPaulo Reis Esselin de Melo332020-01-182020-12-02
Liver Health and Metabolic Function in People With Obesity
Weight loss surgery - Non-Alcoholic Fatty Liver Disease
Not applicableCompletedWashington University School of Medicine232019-02-012025-06-19
Roux-en-Y vs. Roux-en-Y+ Pouch for D2 Total Gastrectomy
Roux-en-Y anastomosis, Roux-en-Y+Pouch anastomosis - Gastric Cancer, Roux-en-y Anastomosis Site
Phase 3UnknownWest China Hospital5882014-08-012018-01-24
Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy
Roux-en-Y for the gastrojejunostomy reconstruction, Billroth II for the gastrojejunostomy reconstruction - Pancreatoduodenectomy
Not applicableCompletedFundacion Miguel Servet642013-11-012016-08-29
Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery
Roux-en-Y, GIP-infusion, GLP-1 - Type 2 Diabetes, Obesity
Phase 1CompletedTurku University Hospital362013-01-012021-10-20
Functional Jejunal Interposition Improve Nutritional Status After Total Gastrectomy
Functional Jejunal Interposition, Roux-en-Y - Gastric Cancer, Nutrition Disorders
Phase 3UnknownSun Yat-sen University5002012-07-012013-11-27
Bariatric Surgery, Arterial Stiffness and Target Organ Damage Study (BASTOD)
Bariatric surgery (Roux-en-y bypass or sleeve gastrectomy) - Hypertension, Obesity
CompletedUniversity Hospital, Montpellier902011-12-012016-12-01
Comparison of Billroth-I and Roux-en-Y Reconstruction After Distal Subtotal Gastrectomy
Billroth-I, Roux en Y - Gastrectomy
Phase 3UnknownAjou University School of Medicine1202010-06-012011-11-07
Pilot Project on Interdisciplinary Therapy of Obesity
Laparoscopic gastric sleeve, Gastric Banding, Multidisciplinary lifstyle intervention - Obesity, Weight Loss
Not applicableRecruitingUniversity of Hohenheim4802009-05-012018-10-26
A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer
Roux-en-Y or Billroth II - Gastric Cancer, Stomach Cancer
Not applicableCompletedNational Healthcare Group, Singapore962008-10-092021-03-09

Conditions studied

Obesity (6)  ·  Stomach Neoplasms (4)  ·  Diabetes Mellitus, Type 2 (2)  ·  Metabolic Syndrome (2)  ·  Neoplasms (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Gastroesophageal Reflux (1)  ·  Hypertension (1)  ·  Intestinal Obstruction (1)  ·  Nutrition Disorders (1)  ·  Weight Loss (1)

Sponsors

Ajou University School of Medicine (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Celia Bañuls (1)  ·  Corewell Health West (1)  ·  Fundacion Miguel Servet (1)  ·  National Healthcare Group, Singapore (1)  ·  Paulo Reis Esselin de Melo (1)  ·  Royal College of Surgeons in Ireland - Medical University of Bahrain (1)  ·  Sun Yat-sen University (1)  ·  Turku University Hospital (1)  ·  University Hospital, Montpellier (1)  ·  University of Hohenheim (1)  ·  Washington University School of Medicine (1)  ·  West China Hospital (1)

Countries

China (2)  ·  France (2)  ·  Spain (2)  ·  United States (2)  ·  Bahrain (1)  ·  Brazil (1)  ·  Finland (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Singapore (1)  ·  South Korea (1)

Top investigators

Asim Shabbir, MBBS (1)  ·  Francisco Javier Herrera, MD (1)  ·  G. Paul Wright, MD (1)  ·  Hoon Hur, M.D. (1)  ·  Jian-Kun Hu, M.D. (1)  ·  John Flood (1)  ·  Junsheng Peng, professor (1)  ·  Matthieu Sardinoux, M.D. (1)  ·  Pirjo Nuutila, Prof (1)  ·  Sang-Uk Han, M.D., Ph D. (1)  ·  Stephan C. Bischoff, Prof. Dr. (1)

Results publications

PMID 15239282, PMID 16240061, PMID 18071862, PMID 22403000, PMID 22657586, PMID 25710027, PMID 28049662, PMID 28096259, PMID 28338153, PMID 28970956, PMID 34523717, PMID 35363252, PMID 42668355